ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669727 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669727; 2) Community: the network communities that were significantly associated with the response to NSC 669727; 3) Molecule: the relationships between components within communities and NSC 669727; 4) MDR: the compounds that were significantly associated with the NSC 669727.

NSC Compound Enrichment Correlation
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.0382675857669585 0.1953522
NSC 678932 1H-Benzimidazole-4-carboxamide, N-[2-(dimethylamino)ethyl]-2-(4-pyridinyl)-, hydrochloride 0.0382675857669585 0.14799674
NSC 679795 Null 0.0382675857669585 0.021344417
NSC 680300 Null 0.0382675857669585 0.36029362
NSC 681635 Camptothecin Derivative 0.0382675857669585 0.66114291
NSC 681639 Camptothecin Derivative 0.0382675857669585 0.70977531
NSC 683414 Null 0.0382675857669585 0.67275553
NSC 687453 2-Propenoic acid, 3-[2,3-dihydro-2-(4-hydroxy- 3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)- 5-benzofuranyl]-, methyl ester, racemic mixture of NSC 674908 and NSC 674996 0.0382675857669585 0.2326893
NSC 693773 Null 0.0382675857669585 0.22979844
NSC 701638 Null 0.0382675857669585 0.12166762
Total:43  Current:29    [First] [Prev] [Next] [Last]